MedPath

Randomized Trial of Depression Follow-up Care by Email

Not Applicable
Completed
Conditions
Depressive Disorders
Interventions
Behavioral: E-mail follow up care
Registration Number
NCT01449890
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

The primary objective of this study is to test in a randomized effectiveness trial if e-mail delivered cognitive behavioural treatment is an effective follow-up care approach in the treatment of depression under clinically representative conditions.

Detailed Description

Depression belongs to the most prevalent mental disorders and often goes along with a high burden of disease. Although the efficacy and the effectiveness of psychological treatments for depressive disorders have been demonstrated, there remains the problem of maintaining the benefits achieved during the initial treatment phase. Therefore options of follow-up care have to be considered. Since access to psychotherapeutic treatments is limited and costly, internet-based interventions can offer a feasible opportunity for follow-up care in order to enhance the long-term effectiveness of psychotherapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • Depressive disorder: F32.0-F32.2; F33.0-F33.2; F34.1 according to ICD-10
  • Precursory CBT
  • Internet access
Exclusion Criteria
  • No knowledge of the German language
  • Risk of suicide
  • Acute psychosis or psychotic symptoms
  • Established concurrent in vivo CBT after discharge from inpatient CBT

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
E-mail follow up careE-mail follow up careAfter having terminated inpatient CBT patients receive follow up care by email for 12 weeks (on average one contact per week). The follow up care aims at supporting the patients in continuing exercises they have learned during the initial treatment phase in order to cope with depression, e.g. integrating positive activities in their all day life or monitoring the interdependence of cognition, emotion and behaviour.
Primary Outcome Measures
NameTimeMethod
Measure of the severity of depression - Beck Depression Inventory (BDI- II)Change in the BDI-II from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
Secondary Outcome Measures
NameTimeMethod
Depressive relapse/recurrenceMeasured at follow up (3 months after termination of the follow-up care)
Measure of health related quality of life - SF-8Change in the SF-8 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care

SF-8: short version of the SF -36

GAD-7Change in the GAD-7 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)

Measure for generalized anxiety disorder

Trial Locations

Locations (1)

University Medical Center Hamburg-Eppendorf, Centre of Psychosocial Medicine, Department of Medical Psychology

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath